Enumera Molecular, Inc. — SEC Form D Filing

Enumera Molecular, Inc. filed an SEC Form D on July 31, 2026, reporting $12.33M raised in Other Health Care.

Form D filing details

Filing
SEC Form D
Filing date
July 31, 2026
Amount reported
$12.33M
Round stage
Series A
Industry
Other Health Care
Website
https://enumeramolecular.com

What the company does

Securities: Equity, Offering of preferred stock and the underlying common stock issuable upon conversion of the preferred stock.. Exemption: Rule 506(b). Incorporated: DELAWARE

Problem

Healthcare organizations struggle with inefficient and error-prone manual processes for managing and analyzing large volumes of molecular data, leading to delays in research, diagnostics, and treatment development.

Solution

Enumera Molecular, Inc. provides a B2B software platform that automates the enumeration, organization, and analysis of molecular data, enabling faster and more accurate insights for research, diagnostics, and therapeutic applications.

Why now

The specific timing catalyst is unclear from available information.

Source: SEC EDGAR Form D filing